Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1CNS 1

Conditions

Smoke Inhalation Injury 1Respiratory Aspiration 1Neoplasms 1Lung Neoplasms 1Lung Diseases, Interstitial 1Lung Diseases 1Brain Neoplasms 1

Interventions

pembrolizumab 602Cyclophosphamide 545Magnetic Resonance Spectroscopy 524Radiotherapy 513Specimen Handling 506Nivolumab 412Cisplatin 380Carboplatin 368Biopsy 306Blood Specimen Collection 302Radiosurgery 290Paclitaxel 280Surveys and Questionnaires 270Gemcitabine 270Standard of Care 267Drug Therapy 263Dexamethasone 263fludarabine 262Bevacizumab 253venetoclax 251Oxaliplatin 209Capecitabine 201Rituximab 198Radiation 192Fluorouracil 189Ipilimumab 188durvalumab 184Doxorubicin 179Etoposide 176atezolizumab 175

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Health Records, Personal × 1 year × Clear all
NCT06836414 2026-04-13

Lung Cancer Screening CT for Firefighters

University of California, San Francisco

Phase NA Withdrawn
Thoracic

Lung Diseases, Lung Neoplasms, Smoke Inhalation Injury, Lung Diseases, Interstitial, Respiratory Aspiration

NCT05102747 2026-01-27

OligoBM-01

Centre Francois Baclesse

Phase NA Recruiting
504 enrolled
CNS

Brain Neoplasms

NCT04732273 2025-09-23

SCCSS-FU

University of Bern

Recruiting
3,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡